Optimal platelet dosing
First published: 19 December 2002
No abstract is available for this article.
REFERENCES
- 1
Harker LA,
Roskos L,
Cheung E.
Effective and efficient platelet transfusion strategies that maintain hemostatic protection (editorial).
Transfusion
1998; 38: 619–21.
- 2
Hersh JK,
Hom EG,
Brecher ME.
Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient.
Transfusion
1998; 38: 637–44.
- 3
Hanson SR,
Slichter SJ.
Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement.
Blood
1985; 66: 1105–9.
- 4
Holme S,
Heaton A.
In vitro platelet aging at 22°C is reduced compared to in vivo aging at 37°C.
Br J Haemost
1995; 91: 212–8.
- 5
Rees GJ,
Slade RS,
Hopes P.
Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.
Eur J Cancer Clin Oncol
1982; 18: 1125–9.
- 6
White JG.
Effects of colchicine and vinca alkaloids on human platelets. I. Influence on platelet microtubules and contractile function.
Am J Pathol
53: 281–91.
- 7
Parizek M,
Kubisz P.
Effects of cytostatic on some platelet functions in vitro. VI. Vinblastine.
Neoplasma
1978; 25: 625–9.
- 8
Hoom CM,
Wagner JG,
Petry TW,
Roth RA.
Toxicity of mito-mycin C toward cultured pulmonary artery endothelium.
Toxicol Appl Pharmacol
1995; 130: 87–94.
